Study IDs Risks to Offspring Associated With Prenatal Opioid Exposure
By Elana Gotkine HealthDay Reporter
FRIDAY, Jan. 19, 2024 -- Prenatal opioid exposure (POE) is associated with an increased risk for infection, eczema and dermatitis, and asthma in offspring, but it is not linked to allergies or anaphylaxis, according to a study published online Jan. 17 in JAMA Network Open.
Erin Kelty, Ph.D., from the University of Western Australia in Crawley, and colleagues compared the risk for hospitalization and emergency department presentation for immune-related conditions in children with and without POE using linked administrative health records for all 401,462 children born between Jan. 1, 2003, and Dec. 31, 2018 (1,656 with POE).
The researchers found that compared with nonexposed neonates, those with POE were more likely to be born preterm, have low birth weight for gestational age, and be coexposed to cigarette smoke. The risks for perinatal infection (adjusted odds ratio [aOR], 1.62) as well as eczema and dermatitis (aOR, 11.91) were increased in association with POE versus nonexposure. Both conditions were also increased in association with neonatal abstinence syndrome (aORs, 2.91 and 31.11, respectively). An increased risk for childhood asthma was also seen in association with POE (adjusted hazard ratio, 1.44) but allergies and anaphylaxis were not. For children with POE from opioids used to treat opioid use disorder but not pain, the risk for childhood eczema and dermatitis was increased. In contrast, POE from opioids used for pain but not to treat opioid use disorder was associated with increased infection risk.
"The findings suggest that POE may modify the developing immune system, changing how the immune system responds to subsequent conditions," the authors write.
Two authors disclosed ties to Mundipharma; one author has a related patent pending.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted January 2024
Read this next
CDC: Decrease in Maternal Mortality Rates Seen in 2022
THURSDAY, May 2, 2024 -- In 2022, there was a decrease in maternal mortality rates, according to a report published in the May Health E-Stats, a publication of the U.S. Centers...
Stigma Affects Quality of Life in Children With Chronic Skin Conditions
TUESDAY, April 30, 2024 -- Health care professionals should consider stigmatization and bullying in assessing the social and mental health of children and adolescents with chronic...
People With Opioid Use Disorder Less Likely to Receive Palliative Care
MONDAY, April 29, 2024 -- People with opioid use disorder (OUD) are less likely to receive palliative care during the last 90 days before death, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.